Oral Presentations
1 October 2015
Poster Sessions
1 October 2015
Meeting‐at‐a‐Glance
1 October 2015
Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum
Shadi Abu‐Hayyeh, Caroline Ovadia, TinaMarie Lieu, Dane D. Jensen, Jenny Chambers, Peter H. Dixon, Anita Lövgren‐Sandblom, Ruth Bolier, Dagmar Tolenaars, Andreas E. Kremer, Argyro Syngelaki, Muna Noori, David Williams, Jose J.G. Marin, Maria J. Monte, Kypros H. Nicolaides, Ulrich Beuers, Ronald Oude‐Elferink, Paul T. Seed, Lucy Chappell, Hanns‐Ulrich Marschall, Nigel W.
Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus–related hepatocellular carcinoma after radiofrequency ablation
Teng‐Yu Lee, Jaw‐Town Lin, Yi‐Siou Zeng, Yi‐Ju Chen, Ming‐Shiang Wu, Chun‐Ying Wu – 1 October 2015 – Radiofrequency ablation (RFA) is the best choice for curative treatment of hepatocellular carcinoma (HCC) cases not suitable for surgical intervention, but efforts should be made to reduce the risk of tumor recurrence. We aimed to investigate the association between nucleos(t)ide analog (NA) therapy for hepatitis B virus (HBV) and the risk of HCC recurrence post‐RFA.
Continuing Medical Education and Disclosures
1 October 2015
Future Meetings
1 October 2015
Category Index
1 October 2015
Development of hyperdynamic circulation and response to β‐blockers in compensated cirrhosis with portal hypertension
Càndid Villanueva, Agustín Albillos, Joan Genescà, Juan G. Abraldes, Jose L. Calleja, Carles Aracil, Rafael Bañares, Rosa Morillas, María Poca, Beatriz Peñas, Salvador Augustin, Joan Carles Garcia‐Pagan, Oana Pavel, Jaume Bosch – 30 September 2015 – Nonselective β‐blockers are useful to prevent bleeding in patients with cirrhosis and large varices but not to prevent the development of varices in those with compensated cirrhosis and portal hypertension (PHT). This suggests that the evolutionary stage of PHT may influence the response to β‐blockers.